Physician

Harvey Robert Chen, MD

According to 2025 Medicare claims, Harvey Chen, MD (NPI: 1144245374) practices cardiac electrophysiology in the Waco, TX market, with the plurality of this provider's patient population coming from Mc Lennan, TX. This provider's primary affiliated billing organization is WACO CARDIOLOGY ASSOCIATES (NPI: 1982607735; TIN: 74-1784088) and primary practice location at 76712-4054. Chen is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Chen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,026 traditional Medicare patients, billed 3,670 HCPCS/CPT codes, and received $279,900 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,202 prescription claims across 506 beneficiaries totaling $440,239 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 12 claims. Open Payments data shows 78 records totaling $4,058. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $51,882 to $440,239. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	368	1,304	$168,032
2016	1,023	2,635	$216,969
2017	1,456	3,535	$252,399
2018	1,554	4,291	$293,948
2019	1,294	3,897	$281,590
2020	1,118	4,010	$266,856
2021	1,074	3,487	$260,100
2022	1,216	3,624	$274,395
2023	1,158	4,021	$248,744
2024	1,026	3,670	$279,900

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	176	686	$51,882
2016	291	1,298	$91,506
2017	365	1,827	$158,607
2018	365	1,973	$208,930
2019	342	1,605	$198,215
2020	325	1,560	$261,383
2021	388	1,745	$305,993
2022	450	1,951	$396,675
2023	487	1,937	$345,668
2024	506	2,202	$440,239

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	16	$32,740
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	14	$30,416
2022	N/R	12	$27,975
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	373	489	$87
93224	Electrocardiogram (ecg) 2-day continuous with review and report by health care professional	104	105	$46
93295	Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days	244	478	$23
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	325	568	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	427	583	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	352	13,804	$259,688
Xarelto	Rivaroxaban	137	6,691	$119,783
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	58	2,400	$10,476
Entresto	Sacubitril/Valsartan	16	480	$10,210
Metoprolol Succinate	Metoprolol Succinate	165	10,960	$3,218

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	78	$4,058	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Harvey Robert Chen, MD?

Tedicare shows public-source Medicare data for Harvey Robert Chen, MD (NPI 1144245374), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Harvey Robert Chen, MD have ACO affiliation data?

Harvey Robert Chen, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Harvey Robert Chen, MD?

Harvey Robert Chen, MD is linked to WACO CARDIOLOGY ASSOCIATES (billing NPI 1982607735) in the available physician profile data.

Does Harvey Robert Chen, MD have Open Payments data?

Harvey Robert Chen, MD has 78 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.